Drug Resistance Monitoring in Cambodia 1997 - 2003.

Slides:



Advertisements
Similar presentations
Anti-Malaria Chemotherapy
Advertisements

Doctors For Life International: An NGO’s perspective on Malaria in Southern Africa Bola Omoniyi, Ph.D. http:
National Malaria Centre of Cambodia Rational Pharmaceutical Management Plus Program World Health Organization European Commission Cambodian Malaria Control.
Shunmay Yeung LSHTM Malaria Day talk April 29, 2010 The problem with drugs…. ……..is they don’t last forever.
Current AH1N1status and MoH Response Measure Sovann Ly, MD, DTMH, MCTM Deputy Director of CDC Department.
SESSION 1: Sharing of Experience in GAFSP Processes in Cambodia, Nepal, Mongolia and Bangladesh (15 minutes to share, 15 minutes for open forum) Lessons.
Drug Policy Bangladesh Presented by Dr ATM Mustafa Kamal National Programme Manager Malaria and Vector Borne Disease Control DGHS, Dhaka, Bangladesh.
1. Health Policy Research Group Department of Pharmacology & Therapeutics, College of Medicine, University of Nigeria Enugu Campus 2. Department of Clinical.
KINGDOM OF CAMBODIA Ministry of Health National Center for Parasitology, Entomology and Malaria Control CNM.
Malaria treatment. Dr abdulrahman al shaikh.. Introduction million patients died because of malaria every year. Most deaths due to Plasmodium Falciparum.
Choice of antimalarial drugs Malaria Medicines & Supplies Services RBM Partnership Secretariat.
Anti-Malaria Drug Policy Philippines
Child Health 2010 Cambodia Demographic and Health Survey.
Malaria Situation & Drug Policy Malaysia Infectious Disease Consultant/Physician MOH Malaysia.
Policy and Regulatory Framework in Power Sector in Cambodia
Abdelkrim Smine, Ph.D. Global Assistance Initiatives Drug Quality and Information Program Twinbrook Parkway Rockville, MD Antimalarial.
New Product Launch 2010 (SC meeting) 29 th October 2009.
1 Diagnosis of HIV Infection in Children HAIVN Harvard Medical School AIDS Initiatives in Vietnam.
Pandemic Response and current activities in Lao PDR NIC Meeting, Beijing, Aug 2009 Dr Phengta Vongphrachanh Director National centre for Laboratory.
ABSTRACT: Problem Statement: Malaria continues to be a major health concern in Africa, South East Asia and Latin America. After years of disease control.
Current National Drug Policies in Lao P.D.R. By Dr Samlane Phompida Centre of Malariology, Parasitology & Entomology.
Issues in malaria diagnosis and treatment May 31, 2007 Jacek Skarbinski, MD Malaria Branch Centers for Disease Control and Prevention.
Informal Consultation to Consolidate the Regional Response to Address Artemisinin Resistance and Substandard Antimalarial Medicines in the GMS, Bangkok,
Cambodia Situation on Patient Safety
Experience on quality of anti-malarials in Lao PDR by Dr.Somthavy CHANGVISOMMID Deputy Director of Food and Drug Department Ministry of Health, Lao PDR.
Kanchanaburi, May 2007 A collaboration between: SMRU, MSF-F, AMI, IRC, ARC, MHD With the participation of TBBC and HIS/CCSDPT Malaria surveillance in camps.
Dr Zahra Rashid Khan, Assistant Professor, Hematology Department of Pathology.
Update on EMIS PDV, ESWG April 2013 Sources used: EMIS 12-13, Commune Database 2011, Jim Shoobridge report.
National Prevalence of Transmitted HIV Drug Resistance in Swaziland in 2011 R. Suzanne Beard, Ph.D. Abstract/poster: TUPDC0103.
MTN-016 TRAINING Infant HIV Testing Urvi M Parikh, Ph.D. University of Pittsburgh Pittsburgh, PA USA.
An update of artemisinin resistance and its containment efforts
Molecular Monitoring in CML the process and questions we can answer Letizia Foroni.
Pharmacies: Partners in the Fight Against TB PATH Hara Mihalea CHE, MPH Tuberculosis and Public Health Consultant
Malaria Endemic Areas and Drug Resistance
Maternal Health 2010 Cambodia Demographic and Health Survey.
Adult and Child Mortality 2010 Cambodia Demographic and Health Survey.
Is antimalarial treatment in pregnant women as effective as that in non- pregnant women? Elizabeth Juma, Rashid Aman, Florence Oloo, Bernhards Ogutu Centre.
Jaran Eriksen MD, PhD Student International Health (IHCAR) & Clinical Pharmacology Karolinska Institute, Stockholm, Sweden.
Bureau of Vector Borne Disease Control, Thailand. TES result in
Anti-Malaria Chemotherapy
Basic Essential Package of Activities for Malaria Pre-elimination in Sampov Loun OD Siemreap, February 26 th, 2016.
Malaria Chemoprophylaxis and treatment By Mohammed Mahmoud, MD.
HEALTH INFORMATICS PUBLIC PRIVATE PARTNERSHIP Project in Cambodia Mr. Phath Veasna Data Management Officer National Center for HIV/AIDS, Dermatology and.
Malaria Infection and Treatment by Mahmoud Lubbad
Malaria: Plasmodium sp.
Hindu College of PG Courses
Closing in on the reservoir:
South Sudan Surveillance Highlights – IDSR & EWARN
Animal Health Situation in Cambodia
Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam  Mallika Imwong, Tran T Hien, Nguyen T Thuy-Nhien, Arjen M Dondorp,
Unit 7: Africa #12 - Disease in Africa.
ARULANANDAM TERENCE.T 403(A)
Male population aged 15-49⃰ Ratio MSM per 1000 male population
© The Author(s) Published by Science and Education Publishing.
TECHjOSH.COM TechJosh.com.
Hemispheres, Latitude & Longitude
2010 Cambodia Demographic and Health Survey
دانشگاه شهیدرجایی تهران
تعهدات مشتری در کنوانسیون بیع بین المللی
2016 JAG Secretariat: DCA/CA & PIN Paul Conrad, PIN DM PM
Claude Fauquet GCP21 Cambodia; Sept 18, 2018
2010 Cambodia Demographic and Health Survey
Spread of a single multidrug resistant malaria parasite lineage (PfPailin) to Vietnam  Mallika Imwong, Tran T Hien, Nguyen T Thuy-Nhien, Arjen M Dondorp,
WS on Surveillance & Epidemiology
Pharmacology 3 antimalarial drugs lecture 11 by Prof.Dr. Mohamed Fahmy
WHO Community drug use practices in malaria in Cambodia: a cross-sectional study National Malaria Centre of Cambodia Rational Pharmaceutical Management.
FAWCO & Water Changing the flow…
HIV/AIDS-Related Knowledge, Attitudes, and Behavior
Integrated Vector Management Programme Jamaica
Situation Report No. 2 – Floods in Cambodia Version 2.0
Presentation transcript:

Drug Resistance Monitoring in Cambodia

Sensitivity (S or S/RI) at 4 sentinel sites 1991 – 97 Western areas: Battambang, Pursat, Eastern areas:Ratanakiri, Kratie  Chloroquine (West): S or S/RI = 3-12% (East): S/RI = 76%-86%  Fansidar® (West): S or S/RI = 0-13% (East): S or S/RI = 57-80%  Quinine and Tetracycline (All areas):S/RI = 100 %  Mefloquine monotherapy: (West): S or S/RI = 80%-97% (East): S or S/RI = 100%

Drug Resistance Monitoring in Cambodia 1998  No study  Lack of budget  Lack of human resources due to Dengue due to Dengue epidemic outbreak

Mefloquine25mg Drug Resistance of Chloroquine & Mefloquine Monotherapy 1999 Sampov Loun Rovieng Mefloquine25mg Chloroquine Mefloquine25mg/kgw

Drug Resistance Artecom in Cambodia 1999 Sampov Loun snoul Artecom(Art.+piperaq.+trimetho prime) 2days,28days follow up

Drug Resistance of A+M in Cambodia 2000 Sampov Loun Oral,Kg Speu

Samlot Snoul Drug Resistance of A+M Monitoring2001

Drug Resistance of Artekine 2 & Coarterm 2001 Anlong Veng Artekine Artekine Coarterm 38 15

N=82 Drug Resistance Monitoring A+M in Cambodia 2002 N=36 N=75 Preah Vihear Pailin Veal Veng Ratanakiri Snoul

Drug Resistance of Artekine 2 & Coarterm in Cambodia 2002 Sampov Loun Snoul Coarterm N=55 N=65 Artekine 2.

Drug Resistance Monitoring A+M in Cambodia 2003 Name of sites No. of enrollment Drop outACPRLTF Oral97 (64.7%) 06 (6.2%) 88 (96.7%) 03 a (3.3%) Anlong Veng 92 (61%) 02 (2.2%) 88 (97.8%) 02 b (2.2%) Snoul66 (41.8%) 03 (4.5%) 63 (100%) 0 Sampov loun 55 (21%) 03 (5.5%) 48 (92.7%) 4 c (7.3%) a = PCR confirmed all cases are recrudescing b = Showed that both are re – infection c = PCR confirmed all cases are recrudescing PCR were done by Institute Pasteur of Cambodia

Drug Resistance Monitoring at sentinel sites, Cambodia 2002 & 2003 YearName of sitesNo. of enrollment ACPR (%)LTF (%) 2002Pailin Pursat Prah vihear Rattanakiri Battambang Kg. Speu Kratie O. M. Chey

Sentinel sites of drug resistance monitoring in Cambodia

Conclusion The result showed the sensitivity of A+M still high (ACPR = 92 – 100%) each sentinel site if we compared to the result of previous study. So The A+M can be continue as drug for our first line treatment of malaria.

Test system Days Othe r day Clinical examinationXXXXXXXXX Axillary TemperatureXXXXXXXXX Treatment A+M A=12mg/kg, for 3days M=25mg/kg on day0 X A+M XAXA XAXA ParasitemiaXXXXXXXXX Blood spot (PCR) Blood sampling ( For In Vitro test) XXXX XXX

Thank you for your attention